ICD-10-CM C90.0 is the diagnosis code for Multiple myeloma. This code falls under the section "Malignant neoplasms of lymphoid, hematopoietic and related tissue" within Chapter 2 — Neoplasms (C00-D49). It is a non-billable/non-specific ICD-10-CM code that should not be used for reimbursement. A more specific sub-code is required for billing. Medical coders and healthcare providers use this code to document and classify diagnoses in electronic health records, insurance claims, and clinical databases.
The following conditions should never be coded at the same time as C90.0. They are mutually exclusive:
Understanding where C90.0 sits in the ICD-10-CM classification helps ensure proper coding:
No, C90.0 is a non-billable/non-specific code. You should use a more specific sub-code for billing and reimbursement.
C90.0 is the ICD-10-CM diagnosis code for "Multiple myeloma". It is used by healthcare providers to classify and document this condition in medical records and insurance claims.
The parent code of C90.0 is C90 ("Multiple myeloma and malignant plasma cell neoplasms"). C90.0 provides a more specific classification within this category.
C90.0 is located in Section C81-C96 — "Malignant neoplasms of lymphoid, hematopoietic and related tissue" within Chapter 2 of the ICD-10-CM Tabular List.
C90.0 has 3 sub-code(s) that provide more specific detail: C90.00, C90.01, C90.02.
Use C90.0 when the patients documented diagnosis matches "Multiple myeloma" and the clinical documentation supports this level of specificity. Always verify with the latest ICD-10-CM guidelines and payer requirements.
The ICD-10-CM code for Multiple myeloma is C90.0.
No, C90.0 is non-billable. Use a more specific sub-code for primary diagnosis billing.
C90.0 is in Chapter 2 of the ICD-10-CM Tabular List.
Type 1 Excludes for C90.0 include: solitary myeloma (C90.3-); solitary plasmactyoma (C90.3-).
Yes, C90.0 is a valid ICD-10-CM code for the 2026 fiscal year, subject to official CMS updates.